All Stories

  1. Opioid addiction and substance misuse or abuse
  2. Mesolimbic dopamine signaling in acute and chronic pain
  3. Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine
  4. Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
  5. Beyond a Simple Anesthetic Effect: Lidocaine in the Diagnosis and Treatment of Interstitial Cystitis/bladder Pain Syndrome
  6. Does the kappa opioid receptor system contribute to pain aversion?
  7. Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408
  8. Correlation Between Ventral Striatal Catecholamine Content and Nociceptive Thresholds in Neuropathic Mice
  9. Prolonged morphine treatment alters δ opioid receptor post‐internalization trafficking
  10. Toll-Like Receptor 4 Mutant and Null Mice Retain Morphine-Induced Tolerance, Hyperalgesia, and Physical Dependence
  11. Migraine and Reward System—Or Is It Aversive?
  12. Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
  13. New Developments in the Pathophysiology of Genital Pain: Role of Central Sensitization
  14. Select G-Protein-Coupled Receptors Modulate Agonist-Induced Signaling via a ROCK, LIMK, and β-Arrestin 1 Pathway
  15. Changes in morphine reward in a model of neuropathic pain
  16. Stereo-selective inhibition of spinal morphine tolerance and hyperalgesia by an ultra-low dose of the alpha-2-adrenoceptor antagonist efaroxan
  17. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl− homeostasis
  18. Opioid Receptor Trafficking in Pain States
  19. Opioid Peptide Co-localization and Release
  20. Intrathecal Catheterization Influences Tolerance to Chronic Morphine in Rats
  21. Myofascial Pain in Patients Waitlisted for Total Knee Arthroplasty
  22. A piece of the puzzle is revealed for delta opioid receptor-mediated analgesia
  23. Low Dose Alpha-2 Antagonist Paradoxically Enhances Rat Norepinephrine and Clonidine Analgesia
  24. Mapping of neural activity produced by thermal pain in the healthy human spinal cord and brain stem: a functional magnetic resonance imaging study
  25. Ultra-Low Dose Naltrexone Attenuates Chronic Morphine-Induced Gliosis in Rats
  26. TNF-α and neuropathic pain - a review
  27. Spatial normalization, bulk motion correction and coregistration for functional magnetic resonance imaging of the human cervical spinal cord and brainstem
  28. Nuclei-and condition-specific responses to pain in the bed nucleus of the stria terminalis
  29. Spinal administration of a δ opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
  30. Behavioural and Morphological Evidence for the Involvement of Glial Cell Activation in Delta Opioid Receptor Function: Implications for the Development of Opioid Tolerance
  31. Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain
  32. Trafficking of δ-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia
  33. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: Diurnal pain variation and effects of analgesic therapy
  34. Remodelling of spinal nociceptive mechanisms in an animal model of monoarthritis
  35. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain
  36. Enhanced thermal antinociceptive potency and anti-allodynic effects of morphine following spinal administration of endotoxin
  37. Receptor-mediated internalization of [3H]–neurotensin in synaptosomal preparations from rat neostriatum
  38. Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist
  39. Internalization and trafficking of opioid receptor ligands in rat cortical neurons
  40. Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: Evidence for somatodendritic labeling and antigen-specific cellular compartmentalization
  41. Evidence that DHPG-induced nociception depends on glutamate release from primary afferent C-fibres
  42. Spinal NGF Restores Opioid Sensitivity in Neuropathic Rats: Possible Role of NGF as a Regulator of CCK-Induced Anti-Opioid Effects
  43. Priming enhances endotoxin-induced thermal hyperalgesia and mechanical allodynia in rats
  44. Intrathecal administration of the mGluR compound, (S)-4CPG, attenuates hyperalgesia and allodynia associated with sciatic nerve constriction injury in rats
  45. Substance P releases and augments the morphine-evoked release of adenosine from spinal cord
  46. Synergy between receptors mediates adenosine release from spinal cord synaptosomes
  47. ATP release from dorsal spinal cord synaptosomes: characterization and neuronal origin
  48. Involvement of Calcium Channels in Depolarization-Evoked Release of Adenosine from Spinal Cord Synaptosomes
  49. Influence of calcium on the release of endogenous adenosine from spinal cord synaptosomes
  50. Opioid Peptide Co-Localization and Release
  51. Opioid Receptor Trafficking in Pain States